In conclusion, our study demonstrated that HOXD-AS1 knockdown improved DDP sensitivity of gastric cancer cells by epigenetically silencing PDCD4, providing a promising therapeutic target to overcome DDP resistance in gastric cancer. This evidence concerns the gene PDCD4 and gastric cancer.